REGN vs. V

In the year-to-date period, REGN achieves a -19.39% return, which is significantly lower than V's -0.75% return. Over the past 10 years, REGN has underperformed V with an annualized return of 2.66%, while V has yielded a comparatively higher 17.74% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Visa Inc. (V). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current REGN Sharpe Ratio is -1.48, which is lower than the V Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of REGN and V, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

REGN's dividend yield for the trailing twelve months is around 0.15%, less than V's 0.71% yield.

The maximum REGN drawdown since its inception was -91.81%, which is greater than V's maximum drawdown of -51.90%. Use the drawdown chart below to compare losses from any high point for REGN and V. For additional features, visit the drawdowns tool.

The current volatility for Regeneron Pharmaceuticals, Inc. (REGN) is NaN%, while Visa Inc. (V) has a volatility of NaN%. This indicates that REGN experiences smaller price fluctuations and is considered to be less risky than V based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Visa Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.